Christopher N Schmickl, MD, PhD
University of California, San Diego
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher N Schmickl, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05951023 · Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)University of California, San Diego · completed · Obstructive Sleep Apnea · principal investigator
- Ph2NCT05804084 · Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep ApneaUniversity of California, San Diego · recruiting · Obstructive Sleep Apnea · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Acetazolamide to Improve Clinically Important Outcomes in Obstructive Sleep Apnea Patients with a High Loop Gain EndotypeK23HL161336 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christopher Nikolaus Schmickl · fiscal years 2022 to 2026Named on NCT05804084
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.